World Interventional Cardiology & Peripheral Vascular Devices Market by Product - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ID: 3772947
  • Report
  • Region: Global
  • 130 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B Braun Melsungen AG
  • C R Bard Inc
  • Cardinal Health Inc
  • Cook Medical Inc
  • Medtronic plc
  • MORE
World Interventional Cardiology & Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Accessories) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Interventional cardiology is a branch of cardiology that focuses on catheter-based technologies for the treatment of structural heart diseases. Catheterization is used to perform large number of procedures on heart. It involves the insertion of a sheath into the femoral artery or any large peripheral artery or vein, and cannulating the heart under X-ray visualization (commonly known as fluoroscopy). However, numerous interventional devices are used for treating peripheral vascular disorders that affect the circulatory system, resulting in plaque built-up in the arteries of arms and legs. Some of the interventional devices used in the market include balloons, catheters, guidewires, stents, and filters.

The world interventional cardiology & peripheral vascular devices market was $13,203 million in 2015 and is expected to reach $25,349 million by 2022 with a CAGR of 9.7%. Rise in prevalence of cardiovascular disorders, geriatric population, demand for minimally invasive procedures, and rapid technological advancements in these devices driven the market. According to the American Heart Association, approximately 5.5 million individuals are affected by heart failure in the U.S., and approximately 670,000 new cases of heart failure are diagnosed every year. According to the Heart & Stroke Foundation, Canada, approximately 66,000 Canadians succumbed to cardiac abnormalities and stroke in 2012. These estimates are expected to boost the demand for interventional cardiology & peripheral vascular devices in the coming years.

On the other hand, complications related to implantation of interventional cardiology & peripheral vascular devices, product recall & failure, and availability of effective conventional treatment options restrict the market growth. Conversely, development of bioabsorbable stents offers key opportunity to market players. Unfavorable reimbursement policies for interventional cardiology & peripheral vascular devices across various regions (mainly the developing countries) are major hindrances for the market growth.

The report segments the market based on product and geography. Based on product, the market is classified into angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Angioplasty stents accounted for the major share of market in 2015; whereas plaque modification devices are the fastest growing segment during the forecast period. Plaque modification before a stent implant decreases the chance of restenosis. In addition, increase in prevalence of atherosclerosis and rise in obese population globally also fuel growth of these devices. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions North America accounted for the major share of the overall market in 2015, and Asia-Pacific is expected to be the fastest growing segment during the analysis period.

The market has witnessed several product launches and approvals in the recent years. For instance, in July 2016, Abbott Laboratories received FDA approval for Absorb bioresorbable heart stent. Absorb is a fully dissolvable stent for treatment of coronary artery diseases. This product launch not only enhanced the company’s vascular business, but also provided a better treatment option for blocked vessels of heart.

Key Benefits: FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on product helps understand the type of devices used for treating blockages associated with chronic diseases.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of all geographic regions helps determine the prevailing opportunities in these regions.
Key market players and their strategies are analyzed to understand the competitive outlook of the global market.
Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS

By Product

Angioplasty Balloons
Old/Normal Balloons
Cutting and Scoring Balloons
Drug-eluting Balloons
Angioplasty Stents
Drug-eluting Stents
Bare Metal Stents
Bioabsorbable Stents
Angioplasty Catheters
Angiography Catheters
Guiding Catheters
Endovascular Aneurysm Repair Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Inferior Vena Cava (IVC) Filters
Retrievable Filters
Permanent Filters
Plaque Modification Devices
Thrombectomy Devices
Atherectomy Devices
Hemodynamic Flow Alteration Devices
Embolic Protection Devices
Chronic Total Occlusion Devices
Accessories
Vascular Closure Devices
Introducer Sheaths
Guidewires
Balloon Inflation Devices

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Malaysia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Egypt
Rest of LAMEA
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B Braun Melsungen AG
  • C R Bard Inc
  • Cardinal Health Inc
  • Cook Medical Inc
  • Medtronic plc
  • MORE
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Key players
1.5 Research methodology

1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.2.2.1 Competitive intelligence of companies and their strategies

3.3 Market share analysis, 2015
3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 Growing geriatric population and increasing prevalence of chronic diseases
3.4.1.2 Technological advancements
3.4.1.3 Improving healthcare infrastructure in developing countries
3.4.1.4 Development of minimally invasive procedures
3.4.1.5 Increasing patient awareness

3.4.2 Restraints

3.4.2.1 High treatment cost
3.4.2.2 Stringent approval process for interventional cardiology and peripheral vascular devices

3.4.3 Opportunities

3.4.3.1 Huge market opportunities in developing countries
3.4.3.2 Development of Bioabsorbable stents

3.5 Clinical Trials

CHAPTER 4 WORLD INTERVENTIONAL CARDIOLGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Angioplasty Balloons

4.2.1 Old/Normal balloons
4.2.2 Cutting and scoring balloons
4.2.3 Drug eluting balloons
4.2.4 Key market trends
4.2.5 Key growth factors and opportunities
4.2.6 Market size and forecast

4.3 Angioplasty Stents

4.3.1 Coronary stents

4.3.1.1 Bare-metal stents
4.3.1.2 Drug-eluting stents (DES)
4.3.1.3 Bioabsorbable stents

4.3.2 Peripheral stents
4.3.3 Key market trends
4.3.4 Key growth factors and opportunities
4.3.5 Market size and forecast

4.4 Angioplasty Catheters

4.4.1 Angiography Catheters
4.4.2 Guiding Catheters
4.4.3 Key market trends
4.4.4 Key growth factors and opportunities
4.4.5 Market size and forecast

4.5 Endovascular Aneurysm Repair Stent Grafts

4.5.1 Abdominal aortic aneurysm
4.5.2 Thoracic aortic aneurysm
4.5.3 Key market trends
4.5.4 Key growth factors and opportunities
4.5.5 Market size and forecast

4.6 Inferior Vena Cava (IVC) Filters

4.6.1 Permanent filters
4.6.2 Retrievable filters
4.6.3 Key market trends
4.6.4 Key growth factors and opportunities
4.6.5 Market size and forecast

4.7 Plaque Modification Devices

4.7.1 Thrombectomy devices
4.7.2 Atherectomy devices
4.7.3 Key market trends
4.7.4 Key growth factors and opportunities
4.7.5 Market size and forecast

4.8 Hemodynamic Flow Alteration Devices

4.8.1 Embolic protection devices
4.8.2 Chronic total occlusion devices
4.8.3 Key market trends
4.8.4 Key growth factors and opportunities
4.8.5 Market size and forecast

4.9 Accessories

4.9.1 Vascular closure devices
4.9.2 Introducer sheaths
4.9.3 Guidewires
4.9.4 Balloon inflation devices
4.9.5 Key market trends
4.9.6 Key growth factors and opportunities
4.9.7 Market size and forecast

CHAPTER 5 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 U.S. market size and forecast
5.2.5 Canada market size and forecast
5.2.6 Mexico market size and forecast

5.3 Europe

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.3.4 Germany market size and forecast
5.3.5 France market size and forecast
5.3.6 U.K. market size and forecast
5.3.7 Italy market size and forecast
5.3.8 Spain market size and forecast
5.3.9 Rest of Europe market size and forecast

5.4 Asia-Pacific

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Japan market size and forecast
5.4.5 China market size and forecast
5.4.6 India market size and forecast
5.4.7 Malaysia market size and forecast
5.4.8 Australia market size and forecast
5.4.9 Rest of Asia-Pacific market size and forecast

5.5 LAMEA

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 Brazil market size and forecast
5.5.5 South Africa market size and forecast
5.5.6 Egypt market size and forecast
5.5.7 Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Abbott Laboratories

6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments

6.2 B. Braun Melsungen AG

6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Operating Business Segments
6.2.4 Business Performance
6.2.5 Key Strategic Moves & Developments

6.3 Boston Scientific Corporation

6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves & Developments

6.4 C. R. Bard, Inc.

6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business Performance
6.4.5 Key Strategic Moves & Developments

6.5 Cardinal Health, Inc.

6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.5.4 Business Performance
6.5.5 Key Strategic Moves & Developments

6.6 Cook Medical, Inc.

6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Key Strategic Moves & Developments

6.7 Medtronic plc

6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.7.4 Business Performance
6.7.5 Key Strategic Moves & Developments

6.8 St. Jude Medical, Inc.

6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Business Performance
6.8.5 Key Strategic Moves & Developments

6.9 Terumo Corporation

6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Business Performance
6.9.5 Key Strategic Moves & Developments

6.10 The Spectranetics Corporation

6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Business Performance
6.10.5 Key Strategic Moves & Developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B Braun Melsungen AG
  • C R Bard Inc
  • Cardinal Health Inc
  • Cook Medical Inc
  • Medtronic plc
  • MORE
Interventional Cardiology and Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters) is poised to grow at a CAGR of 9.7% from 2016 to 2022, to reach $25,349 million by 2022. Angioplasty stent systems are estimated to generate the highest revenue among all segments throughout the forecast period, owing to technological advancements and development of bioabsorbable stents. North America held the leading position in the global market in 2015, and is expected to maintain its lead in the future. This is attributed to the increase in incidence of heart failures, changes in lifestyle, and high adoption of interventional cardiology and peripheral vascular devices in the region.

Growth in geriatric population,increase in prevalence of chronic diseases, changes in lifestyle of the people, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. However, stringent approval process for interventional cardiology and peripheral vascular devices is a major factor that hampers the market growth.
Plaque modification devices are projected to be thefastest growing segment, with a CAGR of 13.7% from 2016 to 2022, as these devices provide an efficient alternative when ballooning of arteries fail. In addition, plaque removal is also important before a stent implant as this helps in prevention of restenosis in the arteries. Apart from this, increase in incidences of plaque buildup in coronary as well as peripheral arteries and minimally invasive nature of the procedure will also drive the market.

Bioabsorbable stents system is expected to register a very high CAGR of 46.0% during the forecast period as this system is fully absorbed into the body and eliminates chances of restenosis. In addition, bioabsorbable stents improve endothelial function, avoid the loss of blood, and restore normal vasomotion. This is not possible when bare metal stents are used. Therefore, bioabsorbable stents would grow with a very high growth rate.

Key findings of the Interventional Cardiology and Peripheral Vascular Devices Market:

On the basis of product type, angioplasty stents segment accounted for more than half of the total market in 2015.
Plaque modification devices are expected to grow at high rate (with a CAGR of 13.7%) as use of these devices before stent implant decreases the chances of restenosis.
North America accounted for more than one-third of the total market in 2015, and it is projected to lead the overall market in the forecast period.
Asia-Pacific is expected to be the fastest growing region (with a CAGR of 10.4%) throughout the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of cardiac disorders in this region.

Key players have adopted product development as their key strategy to cater to the changing needs of the industry. Major players operating in this market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Medical, Inc., Medtronic plc, St. Jude Medical, Inc., Terumo Corporation, and The Spectranetics Corporation. As of 2015, Medtronic dominated the overall renal denervation market, followed by Abbott Laboratories and Boston Scientific Corporation.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • B Braun Melsungen AG
  • Boston Scientific Corporation
  • C R Bard Inc
  • Cardinal Health Inc
  • Cook Medical Inc
  • Medtronic plc
  • St Jude Medical Inc
  • Terumo Corporation
  • The Spectranetics Corporation
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll